Flow Cytometry System suits in vitro diagnostics applications.
Press Release Summary:
Supporting 6-color flow cytometry IVD application for routine HIV/AIDS monitoring using one-tube test, benchtop BD FACSCanto(TM) II offers low sample contamination of less than 0.1% between tests and processing speeds up to 10,000 events/sec. It provides automated sample loading with BD FACS(TM) loader or BD(TM) High Throughput Sampler option, enabling walk-away sample acquisition. Integrated fluidics cart holds all fluids necessary for routine operation and maintenance.
Original Press Release:
BD Biosciences Releases BD FACSCanto(TM) II Flow Cytometry System for In Vitro Diagnostics Use
State-of-the-Art Cell Analysis Technology Now Available in U.S.
SAN JOSE, Calif., Sept. 18 /-- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE:BDX), today announced the U.S clearance and release of the BD FACSCanto(TM) II flow cytometry system for in vitro diagnostic (IVD) use.
This new benchtop analyzer supports the first six-color flow cytometry IVD application for routine HIV/AIDS monitoring using a highly efficient one-tube test. Health professionals regularly use flow cytometry to obtain CD4 test results to make important treatment decisions in HIV-infected patients, most notably when the disease has progressed to the point where initiation of antiretroviral treatment (ARV) would be beneficial.
The BD FACSCanto II system offers a range of turnkey IVD applications, as well as the flexibility and cutting-edge performance required for complex life science and clinical research applications, offering an optional 8-color configuration.* The BD FACSCanto II system demonstrates BD Biosciences' continued commitment to the growing need for IVD products. The system is also CE-IVD marked and was released in Europe earlier this year.
The BD FACSCanto II system assists laboratories in achieving quality data quickly and efficiently, offering users high-fluorescence sensitivity, industry-leading low sample contamination of less than 0.1% between tests, and processing speeds of up to 10,000 events per second. Due to its unique performance characteristics, the BD FACSCanto II system greatly facilitates rare event analysis, an important feature for laboratories of all types.
Whether used for clinical research or IVD testing, the BD FACSCanto II system is designed with many automation features that increase laboratory efficiency and productivity. For example, the system provides automated sample loading with the BD FACS(TM) loader or the BD(TM) High Throughput Sampler** option, enabling walk-away sample acquisition and freeing valuable time for laboratory personnel to focus on other tasks. Its integrated fluidics cart holds all fluids necessary for routine operation and maintenance, facilitating automated system cleaning, startup, and shutdown routines to help laboratories focus on what's important -- analysis and reporting of data.
"For more than 30 years, BD flow cytometers have paved the way for state- of-the-art cell analysis, becoming the method of choice for researchers and clinicians who measure and chart characteristics and properties of cells, particularly cells of the immune system," said Bill Rhodes, President, Cell Analysis. "The design of the BD FACSCanto II system brings all of our expertise to bear, providing the latest tool to advance potentially lifesaving research and meet the complex needs of the 21st century clinical laboratory market."
About BD
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs more than 25,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit http://www.bd.com/.
* The system may be configured for 8-color detection for Research Use Only applications. Not for use in diagnostic or therapeutic procedures.
** Product option. Sample introduction for microtiter plates. Research Use Only. Not for use in diagnostic or therapeutic procedures.
For In Vitro Diagnostic Use.
Class 1 (I) Laser Product
CONTACT: Jeff Ezell, Corporate Communications of BD, +1-202-777-1588; or Kerstin Willmann, BD Biosciences Immunocytometry Systems, Marketing, +1-408-954-2685
